FFCP PHASE2:Hg19::chr4:128802038..128802095,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p1@PLK4 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_PLK4_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000503914, ENST00000507249, ENST00000511942, ENST00000513090, ENST00000515069, uc003ifo.2, uc011cgs.1_5end |
EntrezGene: | PLK4 |
HGNC: | 11397 |
UniProt: | O00444 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@PLK4 |
---|
0
10
20
30
40
50
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 3.95e-47 | 235 |
disease of cellular proliferation | 8.92e-45 | 239 |
hematologic cancer | 2.50e-25 | 51 |
immune system cancer | 2.50e-25 | 51 |
organ system cancer | 4.12e-25 | 137 |
cell type cancer | 3.18e-21 | 143 |
leukemia | 3.60e-21 | 39 |
myeloid leukemia | 3.50e-17 | 31 |
carcinoma | 4.80e-17 | 106 |
Showing 1 to 9 of 9 entries